Ticker ASLN – Aslan Pharma ADR – sales, description, marketcap – Tickerday.com

ASLN

Aslan Pharma ADR

–

Index: NASDAQ; Sector: ; Industry: ;

Marketcap: 37.08M; Volume: 86.41K; AvgVol 3m: 79.41K; Beta: –;

Cost estimate:

P/E: –; EPS: –; EPS growth quarter/prev quarter: 59.70%;

EPS growth this year: -5.20%; EPS growth past 5 years: ;

EPS ttm: -1.30;

P/S: ; P/B: ; P/Cashflow: 5.20; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -190.20%; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: ; Insider Transactions:;

Institutional Ownership: 9.20%; Institutional Transactions: 1.98%;

Data update: 07/10/2020.